Mythbusting Medical Writing: Goodbye, Ghosts! Hello, Help!

References

• Adie, S., I. A. Harris, J. M. Naylor, and R. Mittal. 2013. CONSORT compliance in surgical randomized trials: Are we there yet? A systematic review. Annals of Surgery 258 (6):872–78. doi:10.1097/SLA.0b013e31829664b9.
   PubMed Web of Science ®Google Scholar
• Augestad, K. M., G. Berntsen, K. Lassen, J. G. Bellika, R. Wootton, R. O. Lindsetmo, and Study Group of Research Quality in Medical, Informatics, and Decision, Support. 2012. Standards for reporting randomized controlled trials in medical informatics: A systematic review of CONSORT adherence in RCTs on clinical decision support. Journal of the American Medical Informatics Association 19 (1):13–21. doi:10.1136/amiajnl-2011-000411.
   PubMed Web of Science ®Google Scholar
• Bailey, M. 2011. Science editing and its effect on manuscript acceptance time. American Medical Writers Association Journal 26 (4):147–52.
   Google Scholar
• Battisti, W. P., E. Wager, L. Baltzer, D. Bridges, A. Cairns, C. I. Carswell, L. Citrome, J. A. Gurr, L. A. Mooney, B. J. Moore, T. Pena, C. H. Sanes-Miller, K. Veitch, K. L. Woolley, and Y. E. Yarker. 2015. Good publication practice for communicating company-sponsored medical research: GPP3. Annals of Internal Medicine: Epub Ahead of Print. doi:10.7326/M15-0288.
   Google Scholar
• Borenstein, J., and A. E. Shamoo. 2015. Rethinking authorship in the era of collaborative research. Accountability in Research 22 (5):267–83. doi:10.1080/08989621.2014.968277.
   PubMed Web of Science ®Google Scholar
• Breugelmans, R., and J. P. Barron. 2008. The role of in-house medical communications centers in medical institutions in nonnative English-speaking countries. Chest 134 (4):883–85. doi:10.1378/chest.08-1068.
   PubMed Web of Science ®Google Scholar
• Camby, I., V. Delpire, L. Rouxhet, T. Morel, C. Vanderlinden, N. Van Driessche, and T. Poplazarova. 2014. Publication practices and standards: Recommendations from GSK Vaccines’ author survey. Trials 15:446. doi:10.1186/1745-6215-15-446.
   PubMed Web of Science ®Google Scholar
• Chipperfield, L., L. Citrome, J. Clark, F. S. David, R. Enck, M. Evangelista, J. Gonzalez, T. Groves, J. Magrann, B. Mansi, C. Miller, L. A. Mooney, A. Murphy, J. Shelton, P. D. Walson, and A. Weigel. 2010. Authors’ submission toolkit: A practical guide to getting your research published. Current Medical Research and Opinion 26 (8):1967–82. doi:10.1185/03007995.2010.499344.
   PubMed Web of Science ®Google Scholar
• Dowsett, S. A., L. E. Van Campen, and L. A. Bednar. 2010. Developing good scientific publishing practices: One pharmaceutical company’s perspective. Current Medical Research and Opinion 26 (6):1249–54. doi:10.1185/03007991003748880.
   PubMed Web of Science ®Google Scholar
• Flanagin, A. 2007. Ethical and legal considerations. In AMA manual of style. A Guide for authors and editors, eds. C. Iverson, S. Christiansen, A. Flanagin, P. B. Fontanarosa, R. M. Glass, B. Gregoline, S. J. Lurie, H. S. Meyer, M. A. Winker and R. K. Young, 125–300. New York, NY: Oxford University Press, Inc.
   Google Scholar
• Flanagin, A., L. A. Carey, P. B. Fontanarosa, S. G. Phillips, B. P. Pace, G. D. Lundberg, and D. Rennie. 1998. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. Journal of the American Medical Association 280 (3):222–24. doi:10.1001/jama.280.3.222.
   PubMed Web of Science ®Google Scholar
• Gattrell, W., S. Hopewell, K. Young, S. Lang, P. Farrow, R. White, E. Wager, and C. Winchester. 2015. Professional medical writing support improves the quality but not the speed of reporting randomized controlled trials (poster 10). European Meeting of the International Society for Medical Publication Professionals, London, UK, January 20–21.
   Google Scholar
• Ghaemi, S. N. 2013. Postmodern medicine: An analysis of the pharmaceutical industry and its critics. Perspectives in Biology and Medicine 56 (2):223–35. doi:10.1353/pbm.2013.0018.
   PubMed Web of Science ®Google Scholar
• Glasziou, P., D. G. Altman, P. Bossuyt, I. Boutron, M. Clarke, S. Julious, S. Michie, D. Moher, and E. Wager. 2014. Reducing waste from incomplete or unusable reports of biomedical research. The Lancet 383 (9913):267–76. doi:10.1016/S0140-6736(13)62228-X.
   PubMed Web of Science ®Google Scholar
• Global Alliance of Publication Professionals (GAPP):, Woolley, K. L., A. Gertel, C. Hamilton, A. Jacobs, and G. Snyder. 2012. Poor compliance with reporting research results – we know it’s a problem … how do we fix it? Current Medical Research and Opinion 28 (11):1857–60. doi:10.1185/03007995.2012.739152.
   PubMed Web of Science ®Google Scholar
• Gøtzsche, P. C., A. Hrobjartsson, H. K. Johansen, M. T. Haahr, D. Altman, and A. Chan. 2007. Ghost authorship in industry-initiated randomised trials. Public Library of Science and Medicine 4 (1):0047–0051.
   Google Scholar
• Gøtzsche, P. C., J. P. Kassirer, K. L. Woolley, E. Wager, A. Jacobs, A. Gertel, and C. Hamilton. 2009. What should be done to tackle ghostwriting in the medical literature? Public Library of Science and Medicine 6 (2):e23.
   Google Scholar
• Hamilton, C. W., and A. Jacobs. 2011. Evidence of decreased ghostwriting in a series of three surveys of medical communicators conducted between 2005 and 2011 (abstract). American Medical Writers Association Journal 27 (3):115.
   Google Scholar
• International Committee of Medical Journal Editors. 2014. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. http://www.icmje.org/index.html ( accessed February 23, 2015).
   Google Scholar
• Jacobs, A. 2010. Adherence to the CONSORT guideline in papers written by professional medical writers. Write Stuff 19 (3):196–200.
   Google Scholar
• Lang, T. A. 1997. Assessing the productivity and value of a hospital-based editing service. American Medical Writers Association Journal 12 (1):6–14.
   Google Scholar
• Lang, T. A., and M. Secic. 2006. How to report statistics in medicine. Annotated guidelines for authors, editors, and reviewers. 2nd ed. Philadelphia, PA: American College of Physicians.
   Google Scholar
• Langdon-Neuner, E. 2008. Medical ghost-writing. Mens Sana Monographs 6 (1):257–73. doi:10.4103/0973-1229.33006.
   PubMedGoogle Scholar
• Manring, M. M., J. A. Panzo, and J. L. Mayerson. 2014. A framework for improving resident research participation and scholarly output. Journal of Surgical Education 71 (1):8–13. doi:10.1016/j.jsurg.2013.07.011.
   PubMed Web of Science ®Google Scholar
• Mansi, B. A., J. Clark, F. S. David, T. M. Gesell, S. Glasser, J. Gonzalez, D. G. Haller, C. Laine, C. L. Miller, L. A. Mooney, and M. Zecevic. 2012. Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: A joint journal and pharmaceutical industry perspective. Mayo Clinic Proceedings 87 (5):424–29. doi:10.1016/j.mayocp.2012.02.009.
   PubMed Web of Science ®Google Scholar
• Marchington, J. M., and G. P. Burd. 2014. Author attitudes to professional medical writing support. Current Medical Research and Opinion 30 (10):2103–08. doi:10.1185/03007995.2014.939618.
   PubMed Web of Science ®Google Scholar
• Marušić, A., D. Hren, B. Mansi, N. Lineberry, A. Bhattacharya, M. Garrity, J. Clark, T. Gesell, S. Glasser, J. Gonzalez, C. Hustad, M.-M. Lannon, L. A. Mooney, and T. Pena. 2014. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BioMed Central Medicine 12:197–206.
   Google Scholar
• Matheson, A. 2011. How industry uses the ICMJE guidelines to manipulate authorship–and how they should be revised. Public Library of Science Medicine 8 (8):e1001072. doi:10.1371/journal.pmed.1001072.
   Google Scholar
• McHenry, L. B., and J. N. Jureidini. 2008. Industry-sponsored ghostwriting in clinical trial reporting: A case study. Accountability in Research 15 (3):152–67. doi:10.1080/08989620802194384.
   PubMed Web of Science ®Google Scholar
• Moffatt, B. 2013. Orphan papers and ghostwriting: The case against the ICMJE criterion of authorship. Accountability in Research: Policies and Quality Assurance. 20 (2):59–71. doi:10.1080/08989621.2013.767115.
   Google Scholar
• Moher, D. 2014. Along with the privilege of authorship comes important responsibilities. BioMed Central Medicine 12:214.
   Google Scholar
• Mowatt, G., L. Shirran, J. M. Grimshaw, D. Rennie, A. Flanagin, V. Yank, G. MacLennan, P. C. Gotzsche, and L. A. Bero. 2002. Prevalence of honorary and ghost authorship in Cochrane reviews. Journal of the American Medical Association 287 (21):2769–71. doi:10.1001/jama.287.21.2769.
   PubMed Web of Science ®Google Scholar
• Peron, J., D. Maillet, H. K. Gan, E. X. Chen, and B. You. 2013. Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: A systematic review. Journal of Clinical Oncology 31 (31):3957–63. doi:10.1200/JCO.2013.49.3981.
   PubMed Web of Science ®Google Scholar
• Rennie, D., and A. Flanagin. 1994. Authorship! Authorship! Guests, ghosts, grafters, and the two-sided coin. Journal of the American Medical Association 271 (6):469–71. doi:10.1001/jama.1994.03510300075043.
   PubMed Web of Science ®Google Scholar
• Ross, J. S., K. P. Hill, D. S. Egilman, and H. M. Krumholz. 2008. Guest authorship and ghostwriting in publications related to rofecoxib: A case study of industry documents from rofecoxib litigation. Journal of the American Medical Association 299 (15):1800–12. doi:10.1001/jama.299.15.1800.
   PubMed Web of Science ®Google Scholar
• Ross, J. S., T. Tse, D. A. Zarin, H. Xu, L. Zhou, and H. M. Krumholz. 2012. Publication of NIH funded trials registered in ClinicalTrials.gov: Cross sectional analysis. British Medical Journal 344:d7292. doi:10.1136/bmj.d7292.
   PubMed Web of Science ®Google Scholar
• Scherer, R. W., C. Ugarte-Gil, C. Schmucker, and J. J. Meerpohl. 2015. Authors report lack of time as main reason for unpublished research presented at biomedical conferences: A systematic review. Journal of Clinical Epidemiology 68 (7):803–10. doi:10.1016/j.jclinepi.2015.01.027.
   PubMed Web of Science ®Google Scholar
• Select Committee on Health; UK Parliament. 2004. Examination of witnesses (questions 180–199). http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4101414.htm ( accessed December 18, 2014).
   Google Scholar
• Singer, N. 2009. Medical papers by ghostwriters pushed therapy. The New York Times Company, New York, NY, USA, August 5.
   Google Scholar
• Smith, S. M., R. D. Chang, A. Pereira, N. Shah, I. Gilron, N. P. Katz, A. H. Lin, M. P. McDermott, B. A. Rappaport, M. C. Rowbotham, C. Sampaio, D. C. Turk, and R. H. Dworkin. 2012. Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review. Pain 153 (12):2415–21. doi:10.1016/j.pain.2012.08.009.
   PubMed Web of Science ®Google Scholar
• Steinman, M. A., L. A. Bero, M. M. Chren, and C. S. Landefeld. 2006. Narrative review: The promotion of gabapentin: An analysis of internal industry documents. Annals of Internal Medicine 145 (4):284–93. doi:10.7326/0003-4819-145-4-200608150-00008.
   PubMed Web of Science ®Google Scholar
• Stretton, S. 2014. Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literature. British Medical Journal Open 4 (7):e004777. doi:10.1136/bmjopen-2013-004777.
   PubMed Web of Science ®Google Scholar
• Wager, E., K. Woolley, V. Adshead, A. Cairns, J. Fullam, J. Gonzalez, T. Grant, and S. Tortell. 2014. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: The Global Publication survey. British Medical Journal Open 4 (4):e004780. doi:10.1136/bmjopen-2013-004780.
   PubMed Web of Science ®Google Scholar
• Wislar, J. S., A. Flanagin, P. B. Fontanarosa, and C. D. Deangelis. 2011. Honorary and ghost authorship in high impact biomedical journals: A cross sectional survey. British Medical Journal 343:d6128. See also Web extra table 6125 and correction BMJ 2011;6343:d7677. doi:10.1136/bmj.d6128.
   PubMed Web of Science ®Google Scholar
• Woolley, K., J. Ely, M. Woolley, F. Lynch, J. McDonald, L. Findlay, and Y. Choi. 2005. Declaration of medical writing assistance in international, peer-reviewed publications and effect of pharmaceutical sponsorship (abstract). Fifth International Congress on Peer Review and Biomedical Publication, Chicago, IL, September 16–18.
   Google Scholar
• Woolley, K. L. 2006. Goodbye Ghostwriters! How to work ethically and efficiently with professional medical writers. Chest 130 (3):921–23. doi:10.1378/chest.130.3.921.
   PubMed Web of Science ®Google Scholar
• Woolley, K. L., J. A. Ely, M. J. Woolley, L. Findlay, F. A. Lynch, Y. Choi, and J. M. McDonald. 2006. Declaration of medical writing assistance in international peer-reviewed publications. Journal of the American Medical Association 296 (8):932–34.
   Web of Science ®Google Scholar
• Woolley, K. L., R. A. Lew, S. Stretton, J. A. Ely, N. J. Bramich, J. R. Keys, J. A. Monk, and M. J. Woolley. 2011. Lack of involvement of medical writers and the pharmaceutical industry in publications retracted for misconduct: A systematic, controlled, retrospective study. Current Medical Research and Opinion 27 (6):1175–82. doi:10.1185/03007995.2011.573546.
   PubMed Web of Science ®Google Scholar
• World Medical Association. 2013. World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. Journal of the American Medical Association 310 (20):2191–94. doi:10.1001/jama.2013.281053.
   PubMed Web of Science ®Google Scholar
• Yates, T. 2012. Response to “A defense of professional medical writers”. Forbes. http://www.forbes.com/sites/larryhusten/2012/02/14/a-defense-of-professional-medical-writers/ ( accessed October 23, 2014).
   Google Scholar